Latest news
Loading news…
Eiger BioPharmaceuticals
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Palo Alto, California, United States Founded 2008 11-50 employees For Profit
Eiger is a biopharmaceutical company that develops new antiviral agents against novel targets in the treatment of hepatitis.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
36
Ticker
EIGR
NASDAQ
Patents
25
6 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- EIGR
- Exchange
- NASDAQ
- IPO date
- Mar 23, 2016
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
- Active products
- 18
- Patents granted
- 25
- Trademarks
- 6
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $9M
Company Info
- Founded
- 2008
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- Sub-organizations
- 1
- News articles
- 128
- HQ
- Palo Alto, California, United States
- Region
- San Francisco Bay Area, Silicon Valley, West Coast
- Exit date
- Mar 23, 2016
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- 2
- Trend (90d)
- -0.1
- Last leadership hire
- Feb 20, 2024
- Last layoff mention
- Jun 29, 2023
Acquisitions by Eiger BioPharmaceuticals
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Eiger BioPharmaceuticals
Director, Founder
Vice President, Patents and Licensing
Vice President, Regulatory Affairs
Senior Vice President, Head of Corporate Affairs
Vice President, Regulatory
SVP Clinincal & Develoment Operations
Chief Business Officer
36
professional contacts at Eiger BioPharmaceuticals
Contact execs at Eiger BioPharmaceuticals →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Eiger BioPharmaceuticals
Loading news…
FAQs about Eiger BioPharmaceuticals
People who checked this page also checked these
Sectors Eiger BioPharmaceuticals invests & acquires in
Browse the full Acquirezy directory.